Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Ecor1 Capital, Llc Insider Profile

25 Followers

Ecor1 Capital, Llc, Ten Percent Owner at Atara Biotherapeutics, holds 1.55M shares in Atara Biotherapeutics (Ticker: ATRA), holds 347.31K shares in Aktis Oncology, Inc. (Ticker: AKTS), holds 100.37M shares in Adaptimmune Therapeutics (Ticker: ADAPY). Most recently, Ecor1 Capital, Llc Bought ― shares of Atara Biotherapeutics on May 11, 2026 for an estimated value of $4.74M.

Ecor1 Capital, Llc's Trading History

ATRAAtara Biotherapeutics		May 11, 2026Ten Percent OwnerInformative Buy4.74M$12.43M
AKTSAktis Oncology, Inc.		Jan 12, 2026DirectorUninformative Buy―$5.53M
ADAPYAdaptimmune Therapeutics		Jul 30, 2025Ten Percent OwnerInformative Sell6.74M$2.31M
ZYMEZymeworks		Jun 27, 2025Director, Ten Percent OwnerUninformative Buy521.11$657.18M
ITOSiTeos Therapeutics		May 16, 2025―Informative Buy38.68M$108.49M
PRTAProthena		May 06, 2025Ten Percent OwnerInformative Sell50.83M$44.93M
ANABAnaptysBio		Jan 02, 2025Director, Ten Percent OwnerInformative Buy1.10M$380.45M
MRSNMersana Therapeutics		Dec 23, 2024―Uninformative Sell―$329.42M
TNGXTango Therapeutics		Nov 08, 2024Ten Percent OwnerInformative Sell8.42M$241.53M
VYGRVoyager Therapeutics		Jan 11, 2023Ten Percent OwnerInformative Sell7.14M$6.62M
ODTCOdonate		Dec 10, 2021Ten Percent OwnerInformative Sell9.74M$0.00
CRVSCorvus Pharmaceuticals		Oct 01, 2021Ten Percent OwnerInformative Sell25.04M$813.20K
SURFSurface Oncology		Sep 03, 2020―Informative Sell2.38M$5.03M
AKUSAKOUOS		Jul 02, 2020―Uninformative Buy―$26.26M
EIGRQEiger Biopharmaceuticals		Jun 30, 2015―Informative Buy―$24.17M
GNVCGenVec Inc		May 27, 2014―Informative Buy54.04K$6.92M
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Ecor1 Capital, Llc insider profile FAQ

What is the percentage of profitable transactions made by Ecor1 Capital, Llc?
The percentage of profitable transactions made by Ecor1 Capital, Llc is 67%.
What is the average return per transaction made by Ecor1 Capital, Llc?
The average return per transaction made by Ecor1 Capital, Llc is 29.10%.
What stocks does Ecor1 Capital, Llc hold?
Ecor1 Capital, Llc holds: ATRA, PRTA, ADAPY, VYGR, CRVS, EIGRQ, ANAB, ZYME, MRSN, ODTC, SURF, AKUS, ITOS, TNGX, AKTS, GNVC stocks.
What was Ecor1 Capital, Llc’s latest transaction?
Ecor1 Capital, Llc’s latest transaction was an Informative Buy of $4.74M.
What was Ecor1 Capital, Llc's most profitable transaction?
Ecor1 Capital, Llc’s most profitable transaction was an Informative Buy of ANAB stock on January 2, 2025. The return on the trade was 236.40%.
What is Ecor1 Capital, Llc's role in Atara Biotherapeutics?
Ecor1 Capital, Llc's role in Atara Biotherapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.